Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Karaboyas

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Seminars in Dialysis|September 7, 2020
Temporal changes in dialysate [Na<sup>+</sup>] prescription from 1996 to 2018 and their clinical significance as judged from a meta-regression of clinical trialsMark R Marshall, Angelo Karaboyas
Atherosclerosis|October 19, 2021
Statin initiation in dialysis patients: The hardship of non-prescriptionManfred Hecking, Angelo Karaboyas, Gerit-Holger Schernthaner, et al.
Nephrology News & Issues|March 7, 2014
Current evidence argues against lowering the dialysate sodiumFritz Port, Manfred Hecking, Angelo Karaboyas, et al.
American Journal of Nephrology|April 24, 2022
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically TransientDavid A Goodkin, Junhui Zhao, Aleix Cases, et al.
Seminars in Dialysis|September 11, 2014
Dialysate bicarbonate and the risk of deathFrancesca Tentori, Hal Morgenstern, Angelo Karaboyas, et al.
Clinical Epidemiology|November 18, 2020
Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis PatientsAngelo Karaboyas, Hal Morgenstern, Nancy L Fleischer, et al.
Jornal Brasileiro De Nefrologia|April 17, 2026
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney diseaseDhajanae Sylvertooth, Brian Bieber, Roberto Pecoits-Filho, et al.
American Journal of Nephrology|March 20, 2014
Potassium-binding resins: Associations with serum chemistries and interdialytic weight gain in hemodialysis patientsMichel Jadoul, Angelo Karaboyas, David A Goodkin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 4, 2024
Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin levelNorio Hanafusa, Lisa Henn, Brian Bieber, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 18, 2014
Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern StudyMasaaki Inaba, Angelo Karaboyas, Takashi Akiba, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Seminars in Dialysis|September 7, 2020
Temporal changes in dialysate [Na<sup>+</sup>] prescription from 1996 to 2018 and their clinical significance as judged from a meta-regression of clinical trialsMark R Marshall, Angelo Karaboyas
Atherosclerosis|October 19, 2021
Statin initiation in dialysis patients: The hardship of non-prescriptionManfred Hecking, Angelo Karaboyas, Gerit-Holger Schernthaner, et al.
Nephrology News & Issues|March 7, 2014
Current evidence argues against lowering the dialysate sodiumFritz Port, Manfred Hecking, Angelo Karaboyas, et al.
American Journal of Nephrology|April 24, 2022
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically TransientDavid A Goodkin, Junhui Zhao, Aleix Cases, et al.
Seminars in Dialysis|September 11, 2014
Dialysate bicarbonate and the risk of deathFrancesca Tentori, Hal Morgenstern, Angelo Karaboyas, et al.
Clinical Epidemiology|November 18, 2020
Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis PatientsAngelo Karaboyas, Hal Morgenstern, Nancy L Fleischer, et al.
Jornal Brasileiro De Nefrologia|April 17, 2026
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney diseaseDhajanae Sylvertooth, Brian Bieber, Roberto Pecoits-Filho, et al.
American Journal of Nephrology|March 20, 2014
Potassium-binding resins: Associations with serum chemistries and interdialytic weight gain in hemodialysis patientsMichel Jadoul, Angelo Karaboyas, David A Goodkin, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 4, 2024
Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin levelNorio Hanafusa, Lisa Henn, Brian Bieber, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 18, 2014
Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern StudyMasaaki Inaba, Angelo Karaboyas, Takashi Akiba, et al.
Pageof 9